Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Emervel Volume Lidocaine + Emervel Deep Lidocaine
- Development stage
- Unknown
- Lead developer
- Galderma
- Modality
- Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Small Molecules, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Administration
- Subcutaneous, Intradermal
01
Overview
Emervel Volume Lidocaine and Emervel Deep Lidocaine are hyaluronic acid-based dermal fillers containing 0.3% lidocaine, originally developed by Galderma and now part of the Restylane product line (as Restylane Volyme and Restylane Defyne, respectively). These products utilize Optimal Balance Technology (OBT) to create cross-linked hyaluronic acid gels with specific lifting and integration properties. Emervel Volume is a high-volume filler designed for deep tissue support and facial contouring, while Emervel Deep is intended for the correction of deep wrinkles and folds. In clinical studies conducted by the Hexsel Dermatology Clinic, these two products are used in combination for hand rejuvenation to address the loss of fatty tissue and improve the aesthetic appearance of the dorsal hands. The hyaluronic acid provides immediate physical volume and hydration, while lidocaine serves as a local anesthetic to reduce pain during and after the injection procedure.
- Brand names
- Emervel Deep LidocaineRestylane VolymeRestylane Defyne
- Other names
- Emervel VolumeEmervel Deep
02
Targets
NaV (Voltage-gated sodium channels)
Beyond the preview
Go deeper on Emervel Volume Lidocaine + Emervel Deep Lidocaine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Emervel Volume Lidocaine + Emervel Deep Lidocaine.